Israel Englander Oric Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 196,852 shares of ORIC stock, worth $1.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

196,852

Holding current value

$1.48 Million

% of portfolio

0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$8.04 - $16.03 $1.58 Million - $3.16 Million	196,852 New	196,852 $2.71 Million
Q2 2023 Aug 14, 2023	SELL	$4.95 - $8.4 $5.5 Million - $9.34 Million	-1,111,532 Reduced 49.02%	1,156,110 $8.97 Million
Q1 2023 May 15, 2023	BUY	$4.26 - $6.75 $1.63 Million - $2.59 Million	383,664 Added 20.36%	2,267,642 $12.9 Million
Q4 2022 Feb 14, 2023	BUY	$2.41 - $5.89 $856,441 - $2.09 Million	355,370 Added 23.25%	1,883,978 $11.1 Million
Q3 2022 Nov 14, 2022	BUY	$3.28 - $5.24 $284,149 - $453,946	86,631 Added 6.01%	1,528,608 $4.89 Million

Q2 2022 Aug 15, 2022	BUY	$2.7 - $7.07 $2.87 Million - $7.53 Million	1,064,486 Added 281.99%	1,441,977 $6.46 Million
Q1 2022 May 16, 2022	BUY	$4.54 - $16.1 $1.71 Million - $6.08 Million	377,491 New	377,491 $2.02 Million
Q3 2021 Nov 15, 2021	SELL	$15.9 - $25.22 $3.69 Million - $5.85 Million	-231,853 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$17.37 - $25.34 $1.88 Million - $2.75 Million	108,396 Added 87.8%	231,853 $4.1 Million
Q1 2021 May 17, 2021	BUY	$23.67 - $36.85 $511,153 - $795,775	21,595 Added 21.2%	123,457 $3.03 Million
Q4 2020 Feb 16, 2021	BUY	$20.32 - $39.8 $1.57 Million - $3.08 Million	77,372 Added 315.93%	101,862 $3.45 Million
Q3 2020 Nov 16, 2020	BUY	$19.5 - $31.26 $477,555 - $765,557	24,490 New	24,490 $612,000

Others Institutions Holding ORIC

# of Institutions

113

Shares Held

59.3M

Call Options Held

302K

Put Options Held

7.7K

View Full List

About Oric Pharmaceuticals, Inc.

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $298M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

More about ORIC

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account